Viewing Study NCT06330012


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2025-12-29 @ 8:25 AM
Study NCT ID: NCT06330012
Status: RECRUITING
Last Update Posted: 2024-03-26
First Post: 2024-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module